Canton Strategic Holdings, Inc. is projected to decline to $1.89 by 2027, a -2% move from its current price of $1.93. CNTN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $1.85 | $1.93 | $2.02 | +0.08% |
| Aug 5 | $1.81 | $1.93 | $2.06 | +0.17% |
| Aug 6 | $1.79 | $1.93 | $2.09 | +0.25% |
| Aug 7 | $1.77 | $1.94 | $2.12 | +0.34% |
| Aug 8 | $1.75 | $1.94 | $2.15 | +0.42% |
| Aug 9 | $1.73 | $1.94 | $2.17 | +0.51% |
| Aug 10 | $1.72 | $1.94 | $2.19 | +0.59% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.72 | $1.94 | $2.19 | +0.59% |
| Week 2 | $1.65 | $1.95 | $2.32 | +1.18% |
| Week 3 | $1.59 | $1.96 | $2.42 | +1.78% |
| Week 4 | $1.55 | $1.98 | $2.52 | +2.38% |
| Week 5 | $1.52 | $1.99 | $2.60 | +2.99% |
| Week 6 | $1.49 | $2.00 | $2.69 | +3.59% |
| Week 7 | $1.46 | $2.01 | $2.77 | +4.20% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Canton Strategic Holdings, Inc. (CNTN) engages in the institutional blockchain adoption and digitization of financial markets in the United States. It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-technology, and is involved in the operation of Canton Coin-centric digital asset treasury strategies, including validator operations and network participation; application support and strategic investments; collaboration and ecosystem advancement; capital raising and treasury expansion; token management - locking, lending, and options; Canton Foundation; and governance and risk management.
It also researches and develops GV104, a buccal film formulation of nalmefene for the treatment of respiratory depression and prophylactic protection against synthetic opioid exposure in military and first responders; and GV023, an oral anti-tumor necrosis factor-alpha monoclonal antibody that addresses critical limitation of IV gold standard for the treatment of repeated intravenous infusions. The company was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc.
in February 2026. Canton Strategic Holdings, Inc. was incorporated in 2017 and is headquartered in Red Bank, New Jersey.
CNTN is the asset with a current price of $1.85 and a market cap of $142.68M, ranking 3791. The price outlook is shaped by a bearish near-term technical backdrop, with the stock trading under key moving averages and facing resistance above the current level. The market sits at a confluence of support near $1.85 and a longer-term resistance around $3.54.
A major floor 54.6% below — a decisive break under it would weaken the trend.
The nearest floor, 4.1% below — buyers have tended to step in here.
The nearest ceiling, 73.6% above — a clean break opens room to run.
A major ceiling 100.9% above — clearing it would confirm fresh momentum.
Key CNTN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CNTN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.96 | Sell | $1.95 | Sell |
| MA 10 | $2.01 | Sell | $2.03 | Sell |
| MA 20 | $2.19 | Sell | $2.20 | Sell |
| MA 50 | $2.66 | Sell | $2.58 | Sell |
| MA 100 | $3.04 | Sell | $2.88 | Sell |
| MA 200 | $3.21 | Sell | $3.18 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 35.83 | Neutral |
| Stoch RSI (14) | 44.96 | Neutral |
| CCI (20) | -95.76 | Neutral |
| Williams %R (14) | -85.19 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -19.25 | Sell |
| Bollinger %B (20,2) | 0.18 | Neutral |
| Stochastic %K (14) | 14.81 | Buy |
| TRIX (15) | -1.24 | Sell |
| Awesome (5,34) | -0.58 | Sell |
| Ultimate (7,14,28) | 34.21 | Neutral |
| Momentum (10) | -0.37 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 1.89 | Buy |
| ADX (14) | 24.69 | Sell |
| ATR (14) | 0.10 | Info |
The near-term picture shows bearish sentiment with RSI(14) at 30, suggesting limited upside momentum in the immediate horizon. The price action sits below the 50-day simple moving average of $2.68 and the 200-day simple moving average of $3.21, indicating ongoing downward pressure. The 30-day range spans from $1.37 to $2.51, with a defined support at $1.85 and a resistance at $3.54.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.85 | $1.93 | $2.69 | 0% | Neutral | |
| $1.42 | $1.89 | $2.71 | -2% | Neutral | |
| $1.47 | $2.07 | $3.15 | +7% | Neutral | |
| $1.94 | $2.85 | $4.53 | +48% | Bullish | |
| $1.80 | $2.74 | $4.52 | +42% | Bullish | |
| $1.61 | $2.54 | $4.32 | +32% | Bullish | |
| $1.62 | $2.64 | $4.61 | +37% | Bullish | |
| $1.44 | $2.44 | $4.37 | +26% | Bullish | |
| $1.46 | $2.53 | $4.65 | +31% | Bullish | |
| $1.65 | $2.95 | $5.53 | +53% | Bullish | |
| $1.62 | $3.34 | $6.83 | +73% | Bullish | |
| $3.56 | $7.92 | $18.21 | +310% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.85 | $1.93 | $2.48 | +0.00% |
| September 2026 | $1.78 | $2.14 | $2.68 | +10.99% |
| October 2026 | $1.71 | $2.08 | $2.66 | -2.73% |
| November 2026 | $1.63 | $2.01 | $2.60 | -3.50% |
| December 2026 | $1.65 | $2.06 | $2.69 | +2.24% |
Click any year to see its month-by-month CNTN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, CNTN could reach as high as $2.69, with a base case around $1.93 and support toward $1.85 — roughly 0% from $1.93. Price action looks broadly range-bound.
Expect CNTN to range from $1.42 to $2.71 through 2027. The $1.89 average target implies a -2% move from current prices. That is -2% versus the projected 2026 average. A consolidation phase looks the most probable path here.
The CNTN price prediction for 2028 points to an average of $2.07 (low $1.47, high $3.15) — a potential gain of +7% on today's $1.93. Price action looks broadly range-bound.
In 2029, CNTN is projected to trade between $1.94 and $4.53, averaging $2.85 — a potential gain of +48% from today's $1.93. That is up +38% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Canton Strategic Holdings, Inc.'s 2030 outlook centres on $2.74, within a $1.80 to $4.52 range. That is -4% versus the projected 2029 average. That marks a +42% change versus current levels. Momentum favours further upside here.
By 2031, CNTN could reach as high as $4.32, with a base case around $2.54 and support toward $1.61 — roughly +32% from $1.93. Buyers look set to stay in control over this stretch.
Expect CNTN to range from $1.62 to $4.61 through 2032. The $2.64 average target implies a +37% move from current prices. That is up +4% on the projected 2031 average. Momentum favours further upside here.
The CNTN price prediction for 2033 points to an average of $2.44 (low $1.44, high $4.37) — a potential gain of +26% on today's $1.93. Buyers look set to stay in control over this stretch.
In 2034, CNTN is projected to trade between $1.46 and $4.65, averaging $2.53 — a potential gain of +31% from today's $1.93. That is up +4% on the projected 2033 average. Momentum favours further upside here.
Canton Strategic Holdings, Inc.'s 2035 outlook centres on $2.95, within a $1.65 to $5.53 range. That is up +17% on the projected 2034 average. That marks a +53% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, CNTN could reach as high as $6.83, with a base case around $3.34 and support toward $1.62 — roughly +73% from $1.93. Momentum favours further upside here.
Expect CNTN to range from $3.56 to $18.21 through 2050. The $7.92 average target implies a +310% move from current prices. That is up +137% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CNTN today (≈ 518.134715 CNTN) could be worth
$4,101.84
+$3,101.84 (+310%) by 2050 · US Dollar
Based on the average projected CNTN price of $7.92 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CNTNwould be worth at today's price.
$1,000 invested in CNTN on Jul 31, 2025 (≈ 803.212848 CNTN) would be worth
$1,550.2
+$550.2 (+55.0%) today · 1.55× · US Dollar
Based on a CNTN entry price of $1.25 vs. today's $1.93.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.94 | $994.85 | -0.5% |
| 1 month ago | $2.94 | $656.46 | -34.4% |
| 3 months ago | $3.23 | $597.52 | -40.2% |
| 6 months ago | $5.48 | $352.19 | -64.8% |
| 1 year ago | $1.25 | $1,550.2 | +55.0% |
| All time (4.6y) ago | $1,305 | $1.48 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CNTN forecast.
Our base-case forecast reaches $3.90 around 2050.
Implied market cap at $3.90: $300.78M
The multi-year forecast outlines a transition from neutral to bullish over time, with 2026 expected at min $1.85, avg $1.85, max $2.59 and ROI 0; 2027 with avg $1.79 and ROI -3.4; 2028 with avg $1.96 and ROI 5.7; 2029 showing a notable bullish turn at avg $2.72 and ROI 46.8; 2030 at avg $2.59 and ROI 40.2; 2031 at avg $2.41 and ROI 30; 2032 at avg $2.52 and ROI 36; 2033 at avg $2.29 and ROI 23.7; 2034 at avg $2.38 and ROI 28.4; 2035 at avg $2.78 and ROI 50.1; 2040 at avg $3.15 and ROI 70.4; and 2050 at avg $7.41 and ROI 300.4. The long-run outlook is bullish, with higher potential in the later years, but it remains subject to substantial volatility. The annualized volatility stands at 90%, underscoring the significant risk inherent in the forecast.
Tap a question to reveal the answer.
Avg $2.59, max $4.29, min $1.70; ROI 40.2; sentiment BULLISH.
Forecasts show Neutral in 2026-2028, then BULLISH from 2029 onward; 2029 avg $2.72 with ROI 46.8; 2050 avg $7.41 with ROI 300.4; volatility is high.
Yes, the max forecast for 2035 is $5.22.
Current price $1.85; Market cap $142.68M.
2040 avg $3.15, max $6.46, ROI 70.4; 2050 avg $7.41, max $17.04, ROI 300.4.
Canton Strategic Holdings, Inc. Community Discussion
0Share your Canton Strategic Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.